UARK 2009-32 Compassionate Use Study of Carfilzomib
Status:
No longer available
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This is a compassionate use, open-label, IND study for the purpose of providing carfilzomib
to patients with relapsed or resistant refractory multiple myeloma.